253 related articles for article (PubMed ID: 8018964)
1. The prognostic value of epidermal growth factor receptor (EGF-R) in primary breast cancer: results of a 10 year follow-up study.
Klijn JG; Look MP; Portengen H; Alexieva-Figusch J; van Putten WL; Foekens JA
Breast Cancer Res Treat; 1994 Jan; 29(1):73-83. PubMed ID: 8018964
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer.
Foekens JA; Portengen H; van Putten WL; Trapman AM; Reubi JC; Alexieva-Figusch J; Klijn JG
Cancer Res; 1989 Dec; 49(24 Pt 1):7002-9. PubMed ID: 2555057
[TBL] [Abstract][Full Text] [Related]
3. Tumor angiogenesis in node-negative breast carcinomas--relationship with epidermal growth factor receptor, estrogen receptor, and survival.
Fox SB; Leek RD; Smith K; Hollyer J; Greenall M; Harris AL
Breast Cancer Res Treat; 1994 Jan; 29(1):109-16. PubMed ID: 7517221
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of p53, angiogenesis, and other conventional features in operable breast cancer: subanalysis in node-positive and node-negative patients.
Gasparini G; Toi M; Verderio P; Ranieri G; Dante S; Bonoldi E; Boracchi P; Fanelli M; Tominaga T
Int J Oncol; 1998 May; 12(5):1117-25. PubMed ID: 9538138
[TBL] [Abstract][Full Text] [Related]
5. Prediction of relapse and survival in breast cancer patients by pS2 protein status.
Foekens JA; Rio MC; Seguin P; van Putten WL; Fauque J; Nap M; Klijn JG; Chambon P
Cancer Res; 1990 Jul; 50(13):3832-7. PubMed ID: 2354435
[TBL] [Abstract][Full Text] [Related]
6. The epidermal growth factor receptor as a prognostic marker: results of 370 patients and review of 3009 patients.
Fox SB; Smith K; Hollyer J; Greenall M; Hastrich D; Harris AL
Breast Cancer Res Treat; 1994 Jan; 29(1):41-9. PubMed ID: 8018963
[TBL] [Abstract][Full Text] [Related]
7. EGF-R and steroid receptors in breast cancer: a comparison with tumor grading, tumor size, lymph node involvement, and age.
Zeillinger R; Kury F; Speiser P; Sliutz G; Czerwenka K; Kubista E
Clin Biochem; 1993 Jun; 26(3):221-7. PubMed ID: 8392451
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years.
Reed W; Hannisdal E; Boehler PJ; Gundersen S; Host H; Marthin J
Cancer; 2000 Feb; 88(4):804-13. PubMed ID: 10679650
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor in human breast cancer: correlation with steroid hormone receptors and axillary lymph node involvement.
Battaglia F; Scambia G; Rossi S; Panici PB; Bellantone R; Polizzi G; Querzoli P; Negrini R; Iacobelli S; Crucitti F
Eur J Cancer Clin Oncol; 1988 Nov; 24(11):1685-90. PubMed ID: 3061825
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer.
Alexieva-Figusch J; Van Putten WL; Blankenstein MA; Blonk-Van Der Wijst J; Klijn JG
Cancer; 1988 Feb; 61(4):758-68. PubMed ID: 3338038
[TBL] [Abstract][Full Text] [Related]
11. [C-erbB-2, EGF receptor, p53 and PCNA. The prognostic significance of recent tumor markers for lymph node negative breast cancer].
Schönborn I; Minguillon C; Lichtenegger W; Zschiesche W; Spitzer E
Geburtshilfe Frauenheilkd; 1995 Oct; 55(10):566-71. PubMed ID: 8543129
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of epidermal growth factor receptors, determined by both immunohistochemistry and ligand binding assays, in primary epithelial ovarian cancer: a pilot study.
van der Burg ME; Henzen-Logmans SC; Foekens JA; Berns EM; Rodenburg CJ; van Putten WL; Klijn JG
Eur J Cancer; 1993; 29A(14):1951-7. PubMed ID: 8280488
[TBL] [Abstract][Full Text] [Related]
13. Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients.
Esteban JM; Felder B; Ahn C; Simpson JF; Battifora H; Shively JE
Cancer; 1994 Sep; 74(5):1575-83. PubMed ID: 7914825
[TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical detection of epidermal growth factor receptor (EGF-R) in paraffin sections of breast carcinoma tissue: correlation and clinical significance].
Beckmann MW; Tutschek B; Göhring UJ; Engels K; Picard FK; Scharl A; Niederacher D; Schnürch HG
Geburtshilfe Frauenheilkd; 1995 May; 55(5):258-65. PubMed ID: 7607382
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous estimation of epidermal growth factor receptors and steroid receptors in a series of 136 resectable primary breast tumors.
Cappelletti V; Brivio M; Miodini P; Granata G; Coradini D; Di Fronzo G
Tumour Biol; 1988; 9(4):200-11. PubMed ID: 3420376
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of epidermal growth factor receptor lacks prognostic significance for breast carcinoma.
Göhring UJ; Ahr A; Scharl A; Weisner V; Neuhaus W; Crombach G; Holt JA
J Soc Gynecol Investig; 1995; 2(4):653-9. PubMed ID: 9420872
[TBL] [Abstract][Full Text] [Related]
17. Human breast cancer: survival from first metastasis. Breast Cancer Study Group.
Koenders PG; Beex LV; Kloppenborg PW; Smals AG; Benraad TJ
Breast Cancer Res Treat; 1992; 21(3):173-80. PubMed ID: 1515652
[TBL] [Abstract][Full Text] [Related]
18. The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients.
Klijn JG; Berns PM; Schmitz PI; Foekens JA
Endocr Rev; 1992 Feb; 13(1):3-17. PubMed ID: 1313356
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of cathepsin D and c-erbB-2 oncoprotein in a subgroup of node-negative breast cancer patients with low histological grade tumors.
Gaci Z; Bouin-Pineau MH; Gaci M; Daban A; Ingrand P; Métayé T
Int J Oncol; 2001 Apr; 18(4):793-800. PubMed ID: 11251176
[TBL] [Abstract][Full Text] [Related]
20. Discordance of hormone receptor, human epidermal growth factor receptor-2, and Ki-67 between primary breast cancer and synchronous axillary lymph node metastasis.
Kinoe H; Yamanouchi K; Kuba S; Morita M; Sakimura C; Kanetaka K; Takatsuki M; Abe K; Yano H; Matsumoto M; Otsubo R; Hayashida N; Nagayasu T; Eguchi S
J BUON; 2018 Dec; 23(7):60-66. PubMed ID: 30722113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
